Arginine vasopressin levels are elevated and correlate with functional status in infants and children with congestive heart failure

Circulation

Volumn 109, Issue 21, 2004, Pages 2550-2553

  Price, Jack F ^a   Towbin, Jeffrey A ^a   Denfield, Susan W ^a   Clunie, Sarah ^a   Smith, E O ^a   McMahon, Colin J ^a   Radovancevic, Branislav ^b   Dreyer, William J ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b TEXAS HEART INSTITUTE   (United States)

Author keywords

Heart failure; Hormones; Pediatrics

Indexed keywords

ARGIPRESSIN;

ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CORRELATION ANALYSIS; DISEASE SEVERITY; FUNCTIONAL ASSESSMENT; HEART EJECTION FRACTION; HEART LEFT RIGHT SHUNT; HEART LEFT VENTRICLE FAILURE; HORMONE BLOOD LEVEL; HUMAN; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; VASOCONSTRICTION;

ARGININE VASOPRESSIN; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INFANT; MALE; PULMONARY CIRCULATION; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 2642523678     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000129764.84596.EB     Document Type: Article

References (18)

1. Altura BM, Altura BT. Vascular smooth muscle and neurohypophyseal hormones. Fed Proc. 1977;36:1853-1860.
2. St-Louis J, Schiffrin EL. Biological action and binding sites for vasopressin on mesenteric artery from normal and sodium-depleted rats. Life Sci. 1984;35:1489-1495.
3. Creager MA, Faxon DP, Gavras H, et al. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system. J Am Coll Cardiol. 1986;7:758-765.
4. Szatalowicz VL, Arnold PE, Schrier RW, et al. Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. N Engl J Med. 1981;305:263-266.
5. Goldsmith SR, Francis GS, Cowley AW Jr, et al. Increased plasma arginine vasopressin levels in patients with congestive heart failure. J Am Coll Cardiol. 1986;8:779-783.
6. Riegger GA, Liebau G, Kochsiek K. Antidiuretic hormone in congestive heart failure. Am J Med. 1982;72:49-52.
7. Bichet DG, Kortas C, Mettauer B, et al. Modulation of plasma and platelet vasopressin by cardiac function in patients with heart failure. Kidney Int. 1986;29:1188-1196.
8. Nicod P, Biollaz J, Waeber B, et al. Hormonal, global and regional haemodynamic responses to a vascular antagonist of vasopressin in patients with congestive heart failure with and without hyponatremia. Br Heart J. 1986;56:433-439.
9. Yatsu T, Tomura Y, Tahara A, et al. Cardiovascular and renal effects of conivaptan hydrochloride (YM087), a vasopressin V1A and V2 receptor antagonist, in dogs with pacing-induced congestive heart failure. Eur J Pharmacol. 1999;376:239-246.
10. Yatsu T, Kusayama T, Tomura Y, et al. Effect of conivaptan, a combined vasopressin V (1 a) and V (2) receptor antagonist, on vasopressin-induced cardiac and haemodynamic changes in anaesthetised dogs. Pharmacol Res. 2002;46:375-381.
11. Stone CK, Liang C, Imai N, et al. Short-term hemodynamic effects of vasopressin V1-receptor inhibition in chronic right-sided congestive heart failure. Circ. 1988;78:1251-1259.
12. Martin PY, Abraham WT, Lieming XU, et al. Selective V2-receptor vasopressin antagonism decreases urinary aquaporin-2 excretion in patients with chronic heart failure. J Am Soc Nephrol. 1999;10:2165-2170.
13. Nicod P, Waeber B, Bussien JP, et al. Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure. Am J Cardiol. 1985;55:1043-1047.
14. Stewart JM, Zeballos GA, Woolf PK, et al. Variable arginine vasopressin levels in neonatal congestive heart failure. J Am Coll Cardiol. 1988;11:645-650.
15. Ross RD, Bollinger RO, Pinsky WW. Grading the severity of congestive heart failure in infants. Ped Cardiol. 1992;13:72-75.
16. Nielsen S, Chou CL, Marples D, et al. Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc Natl Acad Sci USA. 1995;92:1013-1017.
17. Schrier RW, Fassett RG. Pathogenesis of sodium and water retention in cardiac failure. Renal Failure. 1998;20:773-781.
18. Lawson H. Metabolism of antidiuretic hormones. Am J Med. 1967;42:713-744.